Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering

We are pleased to announce that in the recently released ranking by Israeli league table Legally Israel 100, Greenberg Traurig’s Tel Aviv office has been recognized in nine categories,
Continue Reading Greenberg Traurig Recognized by “Legally Israel 100” In More Areas Than Any Other Law Firm

Greenberg Traurig was pleased to sponsor the Annual OurCrowd Global Investors Summit for the fourth consecutive year. The event, hosted in Jerusalem, traditionally brings together thousands of entrepreneurs, startup companies
Continue Reading Greenberg Traurig Sponsors 2019 OurCrowd Global Investors Summit

Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life
Continue Reading Tel Aviv Office to Host Capital Markets Roundtable for the Life Sciences Industry